M-J Hu1, Q Zhang1, L Liang1, S-Y Wang2, X-C Zheng2, M-M Zhou1, Y-W Yang1, Q Zhong1, F Huang3. 1. Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, No. 81 Meishan Road, Shushan District, Hefei, 230032, Anhui, People's Republic of China. 2. Department of Head and Neck, Breast Surgery, Anhui Provincial Cancer Hospital, No. 107 East Lake Road, Hefei, 230032, Anhui, People's Republic of China. 3. Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, No. 81 Meishan Road, Shushan District, Hefei, 230032, Anhui, People's Republic of China. fenh@ahmu.edu.cn.
Abstract
PURPOSE: Although vitamin D is reportedly associated with various cancers, the association between vitamin D and thyroid cancer is indefinite. We aimed to investigate whether this association applies to thyroid cancer (TC). METHODS: A total of 276 Chinese Han people were recruited in a current matched case-control study. Multivariable conditional logistic regression was computed to estimate the association between plasma 25(OH)D and papillary thyroid cancer (PTC). In addition, we searched relevant studies in PubMed and Web of Science databases before December 2017 to conduct a meta-analysis. RESULTS: In our case-control study, plasma 25(OH)D concentration was inversely associated with PTC risk (highest tertile vs lowest tertile: adjusted OR = 0.25; 95% CI 0.10, 0.61; Ptrend = 0.003). This association was independent of body mass index and physical activity (all adjusted Pinteraction > 0.05). A total of 11 studies were included in the meta-analysis, among which ten studies have been published and one was our case-control study. Compared with 25(OH)D non-deficient group, the pooled OR of TC was 1.42 (95% CI 1.17, 1.73) in the deficient group. Similarly, blood 25(OH)D levels in patients with TC were tend to be lower than those in the controls (SMD = - 0.20, 95% CI - 0.36, - 0.03). CONCLUSIONS: A high level of circulating 25(OH)D was associated with a decreased TC risk. This association has important significance in public health and should, therefore, be further studied.
PURPOSE: Although vitamin D is reportedly associated with various cancers, the association between vitamin D and thyroid cancer is indefinite. We aimed to investigate whether this association applies to thyroid cancer (TC). METHODS: A total of 276 Chinese Han people were recruited in a current matched case-control study. Multivariable conditional logistic regression was computed to estimate the association between plasma 25(OH)D and papillary thyroid cancer (PTC). In addition, we searched relevant studies in PubMed and Web of Science databases before December 2017 to conduct a meta-analysis. RESULTS: In our case-control study, plasma 25(OH)D concentration was inversely associated with PTC risk (highest tertile vs lowest tertile: adjusted OR = 0.25; 95% CI 0.10, 0.61; Ptrend = 0.003). This association was independent of body mass index and physical activity (all adjusted Pinteraction > 0.05). A total of 11 studies were included in the meta-analysis, among which ten studies have been published and one was our case-control study. Compared with 25(OH)D non-deficient group, the pooled OR of TC was 1.42 (95% CI 1.17, 1.73) in the deficient group. Similarly, blood 25(OH)D levels in patients with TC were tend to be lower than those in the controls (SMD = - 0.20, 95% CI - 0.36, - 0.03). CONCLUSIONS: A high level of circulating 25(OH)D was associated with a decreased TC risk. This association has important significance in public health and should, therefore, be further studied.
Entities:
Keywords:
Chinese Han people; Prevention; Risk factor; Thyroid cancer; Vitamin D
Authors: Sohee Park; Chang-Mo Oh; Hyunsoon Cho; Joo Young Lee; Kyu-Won Jung; Jae Kwan Jun; Young-Joo Won; Hyun-Joo Kong; Kui Son Choi; You Jin Lee; Jin Soo Lee Journal: BMJ Date: 2016-11-30
Authors: Abhijit Sen; Konstantinos K Tsilidis; Naomi E Allen; Sabina Rinaldi; Paul N Appleby; Martin Almquist; Julie A Schmidt; Christina C Dahm; Kim Overvad; Anne Tjønneland; Agnetha L Rostgaard-Hansen; Françoise Clavel-Chapelon; Laura Baglietto; Marie-Christine Boutron-Ruault; Tilman Kühn; Verena A Katze; Heiner Boeing; Antonia Trichopoulou; Christos Tsironis; Pagona Lagiou; Domenico Palli; Valeria Pala; Salvatore Panico; Rosario Tumino; Paolo Vineis; Hb As Bueno-de-Mesquita; Petra H Peeters; Anette Hjartåker; Eiliv Lund; Elisabete Weiderpass; J Ramón Quirós; Antonio Agudo; María-José Sánchez; Larraitz Arriola; Diana Gavrila; Aurelio Barricarte Gurrea; Ada Tosovic; Joakim Hennings; Maria Sandström; Isabelle Romieu; Pietro Ferrari; Raul Zamora-Ros; Kay-Tee Khaw; Nicholas J Wareham; Elio Riboli; Marc Gunter; Silvia Franceschi Journal: Br J Cancer Date: 2015-08-27 Impact factor: 7.640
Authors: Anna Markiewicz; Anna A Brożyna; Ewa Podgórska; Martyna Elas; Krystyna Urbańska; Anton M Jetten; Andrzej T Slominski; Wojciech Jóźwicki; Jolanta Orłowska-Heitzman; Grzegorz Dyduch; Bożena Romanowska-Dixon Journal: Sci Rep Date: 2019-06-24 Impact factor: 4.379
Authors: D Gallo; L Mortara; M B Gariboldi; S A M Cattaneo; S Rosetti; L Gentile; D M Noonan; P Premoli; C Cusini; M L Tanda; L Bartalena; E Piantanida Journal: J Endocrinol Invest Date: 2019-10-04 Impact factor: 5.467